Oxytocin promotes socially triggered cataplexy by activating central amygdala neurons in narcoleptic mice
Background
Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness and cataplexy, sudden episodes of muscle weakness triggered by strong emotions like laughter or anger. These debilitating attacks almost exclusively occur during social interactions, yet the precise neural mechanisms linking social cues and emotional processing to cataplexy remain poorly understood. Current treatments often manage symptoms but don't fully address the underlying triggers. This study investigates the role of oxytocin, a neuropeptide known for its prosocial effects, in mediating socially-triggered cataplexy.
Study Design
Researchers utilized a mouse model of narcolepsy to investigate the role of oxytocin in cataplexy. The primary experimental setup involved inducing cataplexy through social reunification. To assess oxytocin's involvement, an oxytocin antagonist was administered to block its effects. The study also employed chemo- and optogenetic manipulations to precisely control the activity of oxytocin receptor-expressing neurons within the central amygdala. Activity of these neurons and oxytocin tone were monitored just before cataplexy episodes. The primary endpoint was the occurrence and frequency of cataplexy episodes.
Results
This study revealed that social reunification reliably triggered cataplexy in narcoleptic mice. Crucially, administration of an oxytocin antagonist effectively blocked these socially induced cataplexy episodes. > Oxytocin tone and the activity of oxytocin receptor-expressing neurons in the central amygdala both significantly increased just prior to cataplexy triggered by social stimuli. Further chemo- and optogenetic manipulations demonstrated that oxytocin-responsive neurons in the central amygdala actively drive cataplexy. This occurs by inhibiting specific brainstem neurons responsible for suppressing muscle atonia, thereby allowing the sudden muscle weakness characteristic of cataplexy. Interestingly, a rewarding stimulus like chocolate, also associated with strong positive emotions, was found to engage this same oxytocin-amygdala pathway, similarly triggering cataplexy in the narcoleptic mouse model.
Key Findings
- Social reunification reliably triggered cataplexy in a mouse model of narcolepsy.
- An oxytocin antagonist blocked socially induced cataplexy episodes.
- Oxytocin tone and
oxytocin receptorneuron activity in thecentral amygdalaincreased before cataplexy. Central amygdalaneurons drive cataplexy by inhibiting brainstem neurons that suppress muscle atonia.- Rewarding stimuli like chocolate also engage the
oxytocin-amygdalapathway to trigger cataplexy.
Why It Matters
These findings fundamentally shift our understanding of cataplexy by identifying oxytocin and the central amygdala as key mediators of emotionally-triggered muscle weakness, particularly in social contexts. Targeting the oxytocin-amygdala pathway could offer novel therapeutic strategies for managing cataplexy in narcolepsy, moving beyond symptomatic relief to address underlying mechanisms. For individuals experiencing cataplexy, this research suggests that interventions modulating oxytocin signaling or amygdala activity might reduce the frequency or severity of episodes, especially those linked to social interactions or rewarding stimuli. While still preclinical, this work provides a clear mechanistic pathway for future drug development.
oxytocin
cataplexy
narcolepsy
central amygdala
preclinical-animal
social behavior